Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
Top Cited Papers
- 5 May 2021
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 397 (10287), 1819-1829
- https://doi.org/10.1016/s0140-6736(21)00947-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort studyThe Lancet, 2021
- COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort studyThe Lancet, 2021
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination SettingThe New England Journal of Medicine, 2021
- Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human seraScience, 2021
- Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adultsNature, 2020
- Comprehensive Analyses of SARS-CoV-2 Transmission in a Public Health Virology LaboratoryViruses, 2020
- Reopening Society and the Need for Real-Time Assessment of COVID-19 at the Community LevelJAMA, 2020
- Negative binomial mixed models for analyzing microbiome count dataBMC Bioinformatics, 2017
- "Herd Immunity": A Rough GuideClinical Infectious Diseases, 2011
- Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studiesBMJ, 2007